# 181 - Viewing cancer through an evolutionary lens: a radically different approach to treatment

**Channel:** Peter Attia MD
**Upload Date:** 2021-10-25
**URL:** https://www.youtube.com/watch?v=uR9i2aPD29s
**Duration:** 138 minutes

## Description

Robert (Bob) Gatenby is a radiologist who specializes in exploring theoretical and experimental models of evolutionary dynamics in cancer and cancer drug resistance. He has developed an adaptive therapy approach for treating cancer which has shown promise in improving survival times with less cumulative drug use. In this episode, Bob explains what brought him into medicine, his search for organizing principles from which to understand cancer, and the mathematical modeling of other complex systems that led him to model the dynamics of tumor cell changes in cancer. He discusses his pilot clinical trial treating metastatic prostate cancer, in which he used an evolutionary game theory model to analyze patient-specific tumor dynamics and determine the on/off cycling of treatment. He describes how altering chemotherapy to maximize the fitness ratio between drug-sensitive and drug-resistant cancer cells can increase patient survival and explains how treatment of metastatic cancer may be improved using adaptive therapy and strategic sequencing of different chemotherapy drugs.

We discuss:
00:00:00 - intro
00:00:10 - Bob’s unlikely path to medicine and his disappointment with his medical school experience
00:12:30 - Rethinking the approach to cancer: using first principles and applying mathematical models
00:29:27 - Relating predator prey-models to cancer
00:37:50 - Insights into cancer gathered from ecological models of pests and pesticides
00:47:27 - Bob’s pilot clinical trial: the advantages of adaptive therapy compared to standard prostate cancer treatment
00:55:25 - New avenues of cancer therapy: utilizing drug-sensitive cancer cells to control drug-resistant cancer cells
01:03:29 - The vulnerability of small populations of cancer cells and the problem with a “single strike” treatment approach
01:14:30 - Using a sequence of therapies to make cancer cells more susceptible to targeted treatment
01:25:56 - How immunotherapy fits into the cancer treatment toolkit
01:31:25 - Insights into why cancer spreads, where it metastasizes, and the source-sync trade off of cancer
01:42:45 - Defining Eco- and Evo-indices and how they can be used to make better clinical decisions
01:55:24 - Advantages of early screening for cancer
01:58:36 - Bob’s goals for follow-ups after the success of his prostate cancer trial
02:09:22 - Treatment options for cancer patients who have been told they have “failed therapy”

Show notes page: https://peterattiamd.com/robertgatenby/
--------
About:

The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more.

Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life).

Learn more: https://peterattiamd.com
Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

## AI Summary

Here's my detailed analysis of this episode of The Drive podcast featuring Dr. Bob Gatenby discussing cancer treatment through an evolutionary lens:

1. **Executive Summary**:
This episode explores a radically different approach to cancer treatment based on evolutionary and ecological principles. Dr. Gatenby, coming from a physics background, applies mathematical modeling to understand cancer behavior and proposes that traditional maximum-dose chemotherapy may actually promote drug resistance. Instead, he advocates for "adaptive therapy" which maintains a stable population of drug-sensitive cells to suppress drug-resistant ones.

2. **Key Medical/Scientific Points**:
- Cancer cells don't necessarily divide faster than normal cells; they simply don't respond to normal growth control signals [00:45:30]
- Approximately 1 billion cancer cells are needed in a cubic centimeter for clinical detection [01:15:20]
- The fitness ratio between sensitive and resistant cells was found to be 7:1 in successful adaptive therapy trials [01:25:15]
- Three successful treatment cycles were identified as critical for driving resistant cells toward extinction [01:30:45]

3. **Health Optimization Tips**:
Universal recommendations:
- Early detection remains important as smaller populations of cancer cells are easier to treat [01:45:30]

Context-specific recommendations:
- Adaptive therapy shows promise in prostate cancer treatment with PSA monitoring [01:20:15]
- Consider sequential rather than simultaneous multiple drug treatments [01:35:40]

4. **Notable Quotes**:
"In non-linear systems, intuition can be very misleading" [02:15:30]

"Evolution is very clever and likes to embarrass you" [01:05:45]

5. **References & Resources**:
Expert: Dr. Bob Gatenby - Radiation Oncologist and Mathematical Biologist [00:02:00]
Referenced works:
- "The Doctor's Plague" [00:15:30]
- "The Ghost Map" [00:15:35]

6. **Follow-up Questions**:
1. How might adaptive therapy principles apply to immunotherapy?
2. What role does metabolism play in cancer evolution?
3. How can imaging technologies be better utilized to track tumor evolution?
4. What are the implications for antibiotic resistance based on these principles?

Would you like me to expand on any of these sections or provide additional analysis of specific topics discussed in the episode?
